Company Overview and News

9
Dispensing disruption: Are pharmacies ready for digital rivals?

2018-07-06 theage.com.au
When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted doses of prescribed drugs direct to consumers’ homes, major US-based pharmacies from CVS Health to Walgreens saw their share prices fall about 10 per cent.
EBOSF RMYHY API RHC EBOSY CVS EBO RMSYF EBO

9
Dispensing disruption: Are pharmacies ready for digital rivals?

2018-07-06 smh.com.au
When Amazon announced its purchase last week of online pharmacy PillPack, which packages and delivers pre-sorted doses of prescribed drugs direct to consumers’ homes, major US-based pharmacies from CVS Health to Walgreens saw their share prices fall about 10 per cent.
EBOSF RMYHY API RHC EBOSY CVS EBO RMSYF EBO

0
ASX lifts for the week despite the looming trade war

2018-07-06 theage.com.au
The Australian sharemarket has ended the week with a fresh 10-1/2-year high on Friday, despite the US going ahead with tariffs that could potentially begin an all-out trade war with China.
DB API EBOSY MS.PRE MS.PRF MS.PRG MS.PRA EBO RSG EBOSF MS.PRI RMGGY MS.PRK RMGGF MS EBO

0
ASX lifts for the week despite the looming trade war

2018-07-06 smh.com.au
The Australian sharemarket has ended the week with a fresh 10-1/2-year high on Friday, despite the US going ahead with tariffs that could potentially begin an all-out trade war with China.
DB API EBOSY MS.PRE MS.PRF MS.PRG MS.PRA EBO RSG EBOSF MS.PRI RMGGY MS.PRK RMGGF MS EBO

29
Markets Live: ASX opens higher, Sigma tumbles

2018-07-02 theage.com.au
Embattled financial services group AMP is preparing to overhaul a core technology system in its banking division, and is understood to have signed a preliminary agreement with global giant Temenos.
WOPEF BLT BHP API BHPBF BBL GMG BHP WPL BHPLF WOPEY

29
Markets Live: ASX opens higher, Sigma tumbles

2018-07-02 smh.com.au
Embattled financial services group AMP is preparing to overhaul a core technology system in its banking division, and is understood to have signed a preliminary agreement with global giant Temenos.
WOPEF BLT BHP API BHPBF BBL GMG BHP WPL BHPLF WOPEY

12
Major banks lead ASX fall

2018-04-26 theage.com.au
The Australian market has closed lower, led by the major banks as the fallout from the royal commission hits the financial services industry.
MS.PRI API MS.PRK RRL MS.PRE MS.PRF MS.PRG MS MS.PRA RGRNF

12
Major banks lead ASX fall

2018-04-26 smh.com.au
The Australian market has closed lower, led by the major banks as the fallout from the royal commission hits the financial services industry.
MS.PRI API MS.PRK RRL MS.PRE MS.PRF MS.PRG MS MS.PRA RGRNF

10
AusCann Group Holdings' receipt of cannabis oils from Canopy Growth is imminent

2018-04-24 proactiveinvestors.com.au
Auscann Group Holdings Limited (ASX:AC8), a leading medical cannabis company, has received an import permit under its existing import licence.
TWMJF API WEED

45
Major banks lead ASX advance

2018-04-23 theage.com.au
The market had been expected to drop amid the fallout from the banking royal commission but instead, the S&P/ASX 200 index finished up 17.2 points, 0.3 per cent, at 5886.
NCMGF NCM RIO BLT RIO API BHPBF RTPPF NCMGY BHP RIO RTNTF BBL BHP BHPLF

45
Major banks lead ASX advance

2018-04-23 smh.com.au
The market had been expected to drop amid the fallout from the banking royal commission but instead, the S&P/ASX 200 index finished up 17.2 points, 0.3 per cent, at 5886.
NCMGF NCM RIO BLT RIO API BHPBF RTPPF NCMGY BHP RIO RTNTF BBL BHP BHPLF

30
CBA less popular than tax man

2018-04-19 ntnews.com.au
The Commonwealth Bank has admitted it has been charging dead customers for financial advice, the banking royal commission heard on Thursday. A 2015 document showed that in one case an adviser for CBA's Count Financial knew his client had been dead for a decade, but continued to charge ongoing service fees.
BLT API BHP EVN BHPBF BBL CAHPF BHP BHPLF

0
API HY profit down but more stores to come

2018-04-19 perthnow.com.au
Pharmacies operator and health and beauty products retailer Australian Pharmaceutical Industries will continue to expand its Priceline Pharmacy network but says consumer sentiment remains challenging.
API

0
Wattle Health Australia delivers record sales as it broadens its product range and enters new markets

2018-04-06 proactiveinvestors.com.au
Wattle Health Australia Ltd (ASX:WHA) has requested a suspension in trading of its securities, but not before it released some impressive March quarter sales figures.
API MTS

0
Bod Australia gains access to more than 2,000 pharmacies through API deal, shares up 26%

2018-04-05 proactiveinvestors.com.au
Bod Australia Ltd’s (ASX: BDA) negotiation of a retail distribution agreement with Australian Pharmaceuticals Industries (ASX:API) has resulted in a major share price rerating.
API

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:API / AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED on message board site Silicon Investor.

Til Capital Ltd. Ethereum Capital
GPC.C - Gunpowder Capital Corporation Capital One Financial Corporation (NYSE:COF)
Coastal Capital Acquisition Corp CPE.H - Capital Pro Egaux Inc.
Empire Capital agreement for 30 Newfoundland claims Cheap Capital IQ Subsitute
Pinetree Capital-PNP-CDNX Newstrike Capital